Table 1.

Differentially expressed protein spots detected by 2-DE and identified by LC-MS/MS

Swiss-Prot entry	Protein name	TPP confidence	Number of peptides	Number of spots	Theoretical MW (kDa)	Theoretical pI	Percent coverage
P18648	Apolipoprotein A-I precursor [Sus scrofa]	1.0000	24	3	30	5.5	46.4
P27917	Apolipoprotein C-III precursor [Sus scrofa]	1.0000	3	1	10	4.8	19.8
P18650	Apolipoprotein E precursor [Sus scrofa]	1.0000	16	4	37	5.6	21.5
Q28936	Fibrinogen A-alpha-chain (Fragment) [Sus scrofa]	1.0000	22	13	47	6.6	30.1
P14477	Fibrinogen beta chain (Fragment) [Sus scrofa]	0.9999	2	2	2.2	4.3	68.4
Q6R6M8	Fibrinogen gamma polypeptide (Fragment) [Sus scrofa]	1.0000	7	9	10	4.4	45.7
P01846	Ig lambda chain C region	1.0000	7	5	11	6.8	59

Significant differences were determined by one-way ANOVA, proteins identified by SEQUEST and validated using the transproteomic pipeline (TPP) via PeptideProphet and ProteinProphet; listed from the left are the Swiss-Prot primary accession number, the protein name, percent confidence, the highest number of peptides sequenced of all the protein spots identified as that particular protein, the number of spots identified as that particular protein, the theoretical MW of that Swiss-Prot protein, the theoretical pI of that Swiss-Prot protein, and the percent of the protein’s sequence that was covered when the number of peptides were as indicated.